Company / Tangible Book Value per Share
Veracyte, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.97
FY2025
5-year range
$4.74 / $6.97
FY2021-FY2025
Trend
+18.8%
vs FY2024
Sector context
#64 of 163
Health Care
What the data says
At $6.97, Veracyte, Inc.'s tangible book value per share ranks #64 of 163 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $1.07 in FY2017 to $8.43 in FY2020.
Based on SEC 10-K filings.
6.97 in FY2025 with a 5-year CAGR of -3.7%.
Improved from $4.74 to $6.97 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +9.4%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Sector benchmark
#64 of 163 in Health CareTop 39% of 163This company $6.97 Sector average $18.18
▼
-61.6% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 18.8% year-over-year.
- Ranks #64 out of 163 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.97 | +18.8% |
| FY2024 | $5.87 | +23.9% |
| FY2023 | $4.74 | -11.1% |
| FY2022 | $5.33 | -20.1% |
| FY2021 | $6.68 | -20.8% |
| FY2020 | $8.43 | +45.6% |
| FY2019 | $5.79 | +148.5% |
| FY2018 | $2.33 | +117.6% |
| FY2017 | $1.07 | -49.3% |
| FY2016 | $2.11 | -5.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026